NCT01972035View on ClinicalTrials.gov

ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation

PHASE2CompletedINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

August 1, 2014

Primary Completion Date

February 28, 2021

Study Completion Date

February 28, 2021

Conditions
Transplantation InfectionEpstein-Barr Virus InfectionsCytomegalovirus Infections
Interventions
DRUG

Valacyclovir

Experimental Arm

DRUG

Valganciclovir

Standard of care

Trial Locations (1)

55455

University of MN, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT01972035 - ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation | Biotech Hunter | Biotech Hunter